Portland
Neuroscience Book Club

Book archive / Book report

Madness and Memory

Stanley B. Prusiner · Report shared May 29, 2026

About this bookDownload text

Prusiner’s Madness and Memory is simultaneously a scientific memoir, a history of neurodegenerative disease research, and a case study in how science changes when evidence collides with deeply entrenched assumptions. The book follows his intellectual progression from neurology resident to Nobel laureate and traces the gradual emergence of the prion hypothesis: the idea that an infectious protein lacking nucleic acid could transmit disease. At the time, this proposal appeared biologically impossible. The scientific resistance was therefore not merely political or personal; it reflected a foundational commitment to the central dogma of molecular biology. What ultimately changed opinion was not rhetoric, but a long sequence of experimental findings that increasingly failed to fit viral explanations while consistently supporting a protein-based mechanism.

Preface & Introduction

Prusiner frames the discovery of prions as a “disruptive innovation” in biology. He explicitly compares prions to technological revolutions that overturn existing paradigms rather than gradually extending them. This framing matters because the resistance to prions becomes one of the central themes of the book.

The introduction also situates prion diseases within a broader neurological context. Prusiner argues that understanding prions may illuminate many neurodegenerative diseases because protein misfolding, aggregation, and templated conformational change appear repeatedly across disorders like Alzheimer’s and Parkinson’s disease.

Chapter 1 - Growing Up

This chapter primarily establishes the personal and intellectual background that shaped Prusiner’s scientific style.

Important themes include:

The chapter is scientifically important because it explains why Prusiner approached neurological disease differently from many clinicians. His background in protein chemistry and purification techniques later became critical. Most neurologists studying slow dementias thought in clinical or virological terms; Prusiner thought like a biochemist.

The chapter also repeatedly emphasizes mentorship:

These scientists taught him:

This background later allowed him to pursue questions many neurologists would not think to ask.

Chapter 2 - The Beginning of an Odyssey

This chapter marks the true beginning of the prion story.

As a neurology resident at UCSF, Prusiner encounters a patient with rapidly progressive dementia and myoclonus who is diagnosed with Creutzfeldt-Jakob disease (CJD).

Several observations deeply affected him:

Prusiner becomes fascinated by the work of Tikvah Alper, who had shown that the “scrapie agent” resisted ultraviolet radiation at levels that should have destroyed nucleic acids. This was one of the earliest major clues against a conventional virus.

The key logical problem emerges here:

Prusiner initially assumes the pathogen must be an unusual virus.

Chapter 3 - A Plethora of Theories

This chapter explores the intellectual chaos surrounding scrapie and CJD research in the 1960s and 1970s.

Researchers proposed numerous explanations:

The field lacked coherence because the data contradicted existing categories.

Several experimental findings complicated viral theories:

Yet researchers remained committed to viral explanations because abandoning nucleic acid inheritance seemed impossible.

Prusiner also begins appreciating the importance of strain variation in scrapie. Different isolates produced distinct disease patterns and incubation times. This created a major challenge for non-genomic theories because strain diversity typically implied genetic encoding.

This became one of the strongest objections to the protein-only hypothesis for many years.

Chapter 4 - The Scrapie Race

Prusiner establishes his own laboratory and commits himself fully to isolating the scrapie agent.

This decision was scientifically risky and professionally dangerous because:

The chapter focuses heavily on biochemical purification strategies.

If the infectious agent could be purified, its composition could be identified, and the viral versus nonviral debate could finally be resolved experimentally.

The challenge was enormous because:

Hamsters became essential experimental models because they shortened incubation times and enabled more practical transmission studies.

A major conceptual shift occurs during these experiments: infectivity increasingly tracked with protein fractions rather than nucleic acid fractions.

This did not yet prove the protein-only hypothesis, but it increasingly weakened viral models

Chapter 5 - Dr. America and the Trembling Cannibals

This chapter centers on kuru research and D. Carleton Gajdusek.

Gajdusek’s work demonstrated that kuru was transmissible and linked to ritual cannibalism among the Fore people of Papua New Guinea.

Scientifically, kuru mattered because:

Prusiner admires Gajdusek’s brilliance but also portrays him as domineering and intensely competitive.

The chapter also demonstrates how epidemiology guided mechanistic thinking:

This further deepened the mystery.

The public and scientific fascination with kuru also increased visibility for prion diseases generally, though most researchers still assumed a slow virus mechanism.

Note that Gajdusek was later involved in a public scandal involving him adopting young boys from Micronesia and Papua New Guinea and educating them in the US while they lived with him. In the 1990s, however, allegations emerged that he had sexually abused some of these boys. In 1997, he pleaded guilty to child molestation charges involving one of them. He served prison time and then left the United States. Hanya Yanagihara’s The People in the Trees is a novel that draws heavily from this story and is very good.

Chapter 6 - The Battle for Tenure

Prusiner’s tenure battle was difficult because many scientists believed:

This chapter repeatedly illustrates a broader point: scientific institutions reward reliability more easily than disruptive hypotheses.

At this stage:

Yet his persistence continued because the biochemical data increasingly pointed toward protein.

Chapter 7 - What’s in a Name?

This chapter describes the introduction of the term “prion.”

The naming was strategically important.

Prusiner wanted terminology that:

The term “prion” (“proteinaceous infectious particle”) immediately generated backlash.

Critics viewed the name as premature because:

Chapter 8 - Lost in the Pacific Fog

This chapter focuses on growing hostility from parts of the scientific community.

Prusiner describes:

Yet the criticism was not purely irrational. Important objections remained unresolved:

The strongest science in the book emerges because critics forced increasingly rigorous experiments.

This becomes one of the book’s most important lessons:

Chapter 9 - The Amyloid Story

This chapter marks a major turning point.

Prusiner and colleagues increasingly connect infectivity with amyloid protein aggregates.

Key observations:

The discovery of protease resistance became crucial because it distinguished pathogenic PrP (prion protein) from normal cellular protein.

This solved several mysteries simultaneously:

Prusiner’s group found that normal brains contained the normal prion protein (PrPᶜ), while diseased brains contained an abnormal, aggregated, amyloid-associated form of the same protein (PrPˢᶜ). This was a huge conceptual breakthrough because infectivity kept tracking with these abnormal protein aggregates rather than with any detectable viral nucleic acid. The amyloid mattered because amyloid is a highly ordered, misfolded protein structure that is unusually stable and resistant to degradation, matching many of the bizarre properties of the scrapie agent. Researchers therefore began considering the possibility that disease was caused not by a hidden virus, but by a normal host protein adopting an abnormal shape that could template other copies of the protein into the same misfolded conformation.

Chapter 10 - Finding the Gene

Identification of the prion protein gene (PRNP) becomes one of the strongest advances supporting the hypothesis.

The key realization:

Disease emerges when this normal protein converts into a pathogenic conformer (PrPˢᶜ).

This finding dramatically shifts the debate because:

Familial prion diseases could now be explained by mutations increasing the likelihood of pathological misfolding.

This chapter strongly advanced acceptance because it unified infectious disease, inherited disease, and sporadic disease under a single mechanistic framework.

That explanatory power became one of the hypothesis’s greatest strengths.

Chapters 11-14 - Press Battles, Human Disease, Protein Shape, and Turf Wars

These chapters collectively show the gradual transition from fringe theory toward mainstream acceptance.

Several developments mattered enormously:

1. Protein conformation became central

Researchers increasingly recognized that biological information might be encoded not only in sequence, but also in shape.

2. Experimental evidence kept accumulating

Repeated failures to identify nucleic acids weakened viral theories further.

3. Transgenic animal experiments became persuasive

Manipulating PrP expression altered susceptibility to disease.

This was critical because infectivity depended on host prion protein, supporting templated conformational conversion. So mice without normal PrP aren’t getting the disease after inoculation, and mice that overexpress normal PrP got the disease faster. Researchers also found that prions transmitted better between animals with similar PrP sequences.

4. Human genetics strengthened the framework

Inherited prion diseases fit naturally into the new model.

The resistance did not disappear instantly. Instead, acceptance changed gradually because:

Chapter 15 - Mad Cow and Other Prion Strains

The emergence of bovine spongiform encephalopathy (BSE) transformed public perception dramatically.

Before BSE prion diseases seemed rare and obscure.

After BSE prions became a global public health issue.

The possibility that infected beef could transmit disease to humans fundamentally changed attitudes.

Importantly, BSE also demonstrated that prions could cross species barriers.

This chapter also revisits the strain problem.

One of the biggest conceptual breakthroughs was realizing that distinct protein conformations themselves may encode strain properties.

This was extraordinary because it implied biological information could be stored structurally rather than genetically.

That insight helped resolve one of the major objections to protein-only inheritance.

Chapter 16 - Stockholm

The Nobel Prize represents symbolic validation of the field.

But the chapter is emotionally more complicated than triumphant.

Prusiner repeatedly reflects on isolation, hostility, uncertainty, and the long delay between evidence and acceptance.

Importantly, acceptance did not occur because one experiment suddenly proved everything. Consensus shifted cumulatively. The story demonstrates how paradigm shifts usually occur not through a single decisive moment, but through gradual erosion of alternative explanations.

Chapter 17 - The Third Judgment of Paris

This chapter broadens the implications of prions. Prusiner increasingly argues that many neurodegenerative diseases may involve prion-like mechanisms:

Prions become less an isolated curiosity and more a new biological principle.

Epilogue - The Quest for Therapeutics

The final section highlights how difficult therapeutic progress remains.

Despite major mechanistic insights diagnosis remains challenging, treatment remains limited, and neurodegeneration remains devastating.

Yet Prusiner remains optimistic that understanding protein misfolding and propagation may eventually enable interventions across multiple diseases.

Modern Hindsight Commentary

In hindsight, the prion story profoundly reshaped neuroscience and molecular biology.

Today, several ideas that once seemed radical are widely accepted:

Research in Alzheimer’s disease now suggests that amyloid-β and tau pathology spread in prion-like ways through neural circuits. Similar mechanisms are being investigated in Parkinson’s disease (α-synuclein), ALS (TDP-43 and SOD1), and Huntington’s disease.

Equally important, the prion story changed how scientists think about biological information itself. Before prions, heredity and replication were almost universally tied to nucleic acids. Prions demonstrated that protein conformation alone can encode biologically meaningful information under certain circumstances.

The field’s eventual acceptance of prions therefore reflected not merely accumulation of data, but a broader conceptual shift:

That conceptual transition is arguably the book’s deepest scientific legacy.

Evidence for prion-like behavior in neurodegenerative disease

In many experimental settings, researchers can spread Alzheimer’s-, tau-, or α-synuclein-type pathology between animals. BUT

experimentally transmissible ≠ naturally contagious.

For example:

So in the lab, these proteins absolutely can behave in transmissible ways.

The reason Alzheimer’s and Parkinson’s are still not considered classical infectious prion diseases is that they seem to lack efficient natural host-to-host transmission.

That difference probably comes from several factors.

1. PrP is uniquely good at becoming infectious

PrP evolved into a protein that, unfortunately, is extraordinarily capable of:

Most other aggregating proteins seem much less robust.

Amyloid-β or tau aggregates may spread cell-to-cell and within a brain, without being especially good at surviving digestion, environmental exposure, peripheral immune clearance, or crossing into another organism’s nervous system.

So they may be excellent intrabody propagators but poor interbody propagators. For Alzheimer’s and Parkinson’s we do not see ordinary contagious spread patterns.

That’s why most researchers avoid calling them fully infectious prion diseases.

But there are weird edge cases

Interestingly, there have been some unsettling findings suggesting limited accidental transmission of amyloid pathology under highly artificial medical circumstances.

For example people exposed decades ago to cadaver-derived growth hormone or dura mater grafts later showed amyloid pathology.

This sparked major discussion about whether amyloid seeding can occasionally be transmitted medically. But these cases are rare, evidence remains incomplete, and they still do not resemble ordinary infectious disease spread.

So the field’s current position is roughly:

Property

Classical prions

AD/PD proteins

Misfolding

Yes

Yes

Templated seeding

Yes

Yes

Strain-like conformers

Yes

Evidence supports

Spread through brain

Yes

Yes

Experimental transmission

Yes

Yes

Natural contagious spread between humans

Yes

No convincing evidence

That’s why “prion-like” has become the dominant compromise term.

Discussion Questions

Club notes from the original shared report. Formatting has been standardized; the substantive notes are preserved. Dates refer to when the report was shared.